<?xml version="1.0" encoding="UTF-8"?>
<fn-group>
 <fn id="d33e447">
  <p id="ntpara0010">
   <bold>Potential Competing Interests:</bold> Dr Baillargeon has received payment for consulting from AbbVie, Auxilium, Endo Pharmaceuticals, and GlaxoSmithKline. Dr Volpi has received a grant from the 
   <funding-source id="gs1">
    <institution-wrap>
     <institution-id institution-id-type="doi">10.13039/100000002</institution-id>
     <institution>National Institutes of Health</institution>
    </institution-wrap>
   </funding-source> (P30 AG024832) and other support from the 
   <funding-source id="gs2">
    <institution-wrap>
     <institution-id institution-id-type="doi">10.13039/100007865</institution-id>
     <institution>University of Texas Medical Branch</institution>
    </institution-wrap>
   </funding-source>. The other authors report no competing interests.
  </p>
 </fn>
</fn-group>
